Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Shanton Pharma’s SAP-001 earns FDA Fast Track status for refractory gout treatment FDA grants Fast Track designation to Shanton Pharma’s SAP-001 for refractory gout; company plans accelerated development and Phase 3 trials. bySoujanya RaviJuly 25, 2025